Article
Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells
7 Jun 2024
Abstract excerpt
Poor prognosis and drug resistance in glioblastoma (GBM) can result from cellular heterogeneity and treatment-induced shifts in phenotypic states of tumor cells, including dedifferentiation into glioma stem-like cells (GSCs). This rare tumorigenic cell subpopulation resists temozolomide, undergoes proneural-to-mesenchymal transition (PMT) to evade therapy, and drives recurrence. Through inference of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
